Response to Tanezumab, as Assessed by Outcome Measures in Rheumatology-Osteoarthritis Research Society International Criteria, in Patients With Osteoarthritis of the Knee or Hip

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2018.02.601
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Onset and Maintenance of Efficacy of Subcutaneous Tanezumab in Patients With Moderate to Severe Osteoarthritis of the Knee or Hip

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Letter to the Editor: Physical Activity as an Outcome Measure for Patients With Hip or Knee Osteoarthritis

Arthritis Care and Research
Rheumatology
2018English

Reliability of the Osteoarthritis Research Society International Recommended Performance-Based Tests of Physical Function in People With Hip and Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Doxycycline for Osteoarthritis of the Knee or Hip

Cochrane Database of Systematic Reviews
2012English

Predictors of Fatigue in Patients With Hip and Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2013English

Outcome of Arthroscopy in Patients With Advanced Osteoarthritis of the Hip

PLoS ONE
Multidisciplinary
2015English

Estimating Braking Performance in Osteoarthritis of the Knee or Hip With a Reaction Timer

Orthopaedic surgery
SurgeryOrthopedicsSports Medicine
2019English

Recommendations of the French Society of Rheumatology for the Pharmacological Management of Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Socioeconomic and Psychosocial Factors Influence Pain or Physical Function in Asian Patients With Knee or Hip Osteoarthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy